Condition: Psoriasis (PsO) · Enthesitis · Psoriasis Arthritis · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
It is an observational, single-center, prospective, exploratory, open-label study to assess the efficacy and safety of IL-17 inhibitors on subclinical enthesitis in patients with moderate to severe psoriasis with subclinical enthesitis based on Power Doppler (PD) Ultrasonography (PDUS)
This description comes directly from the study's public registry record.
Wenjun Hou, Dr · + 86 135 8402 3320 · hwjnanjing@126.com
Always discuss trial participation with your own doctor first.
| Department of Dermatology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Nanjing, Jiangsu, China | Recruiting |
| Department of Dermatology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06987292